Ask An Altascientist - Q&A With Lisa Sanford On First-In-Human Trials
Source: Altasciences
Vice President of Business Development Lisa Sanford explains whether life science teams in Canada need an Investigational New Drug Application before starting a first-in-human trial. In addition, Sanford touches on several reasons why a team might consider conducting their study in the country.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Altasciences
This website uses cookies to ensure you get the best experience on our website. Learn more